Arkolith/Insider Trading/ANIK/Form 4

Colleran David

EVP, General Counsel, Corp SecAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2025Option exercise(M)6K—$050K
Mar 17, 2025Tax withholding(F)2K$15.91$30K48K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2025Option exercise(M)6K—$013K
Mar 14, 2025Grant(A)14K—$014K
Mar 14, 2025Grant(A)28K—$028K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-001532) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML